Proinflammatory CD20 + T cells contribute to CNS-directed autoimmunity

CD20 as a gatekeeper of the resting state of human B cells

(2021) Kathrin Kläsener et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proinflammatory CD20 + T cells are differentially affected by MS therapeutics

(2021) Corinna Quendt et al.   ANNALS OF NEUROLOGY

B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis

(2020) Nitzan Nissimov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pathogenic T cell cytokines in multiple sclerosis

(2019) Catriona A. Wagner et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Anti-CD20 therapy depletes activated myelin-specific CD8+T cells in multiple sclerosis

(2019) Joseph J. Sabatino et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dissection of a circulating CD3+ CD20+ T cell subpopulation in patients with psoriasis

(2018) J. Niu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model

(2018) Larissa C. Da Rosa et al.   DIABETOLOGIA

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

(2018) Carmen Alcalá et al.   JOURNAL OF NEUROLOGY

Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis

(2018) Catherine Uyttenhove et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease

(2018) Darius Häusler et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis

(2018) Marina R von Essen et al.   BRAIN

Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients

(2018) Stefan Gingele et al.   Cells

CD20 role in pathophysiology of Hodgkin’s disease

(2017) Marcelo Antônio Oliveira Santos et al.   Revista da Associacao Medica Brasileira

Features of Human CD3+CD20+T Cells

(2016) Elisabeth Schuh et al.   JOURNAL OF IMMUNOLOGY

Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients

(2014) Arumugam Palanichamy et al.   JOURNAL OF IMMUNOLOGY

MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

(2013) Nicolas Molnarfi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties

(2013) Christian Klein et al.   mAbs

 -Chain-Deficient Mice Possess B-1 Cells and Produce IgG and IgE, but Not IgA, following Systemic Sensitization and Inhalational Challenge in a Fungal Asthma Model

(2012) S. Ghosh et al.   JOURNAL OF IMMUNOLOGY

CXCR3 in T cell function

(2011) Joanna R. Groom et al.   EXPERIMENTAL CELL RESEARCH

A New Vampire Saga: The Molecular Mechanism of T Cell Trogocytosis

(2011) Elaine Pashupati Dopfer et al.   IMMUNITY

Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis

(2011) Nancy L. Monson et al.   PLoS One

Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects

(2011) Paul Eggleton et al.   ARTHRITIS RESEARCH & THERAPY

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

(2010) Martin S. Weber et al.   ANNALS OF NEUROLOGY

CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease

(2010) Romeo Sporici et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Depletion of functionally active CD20+ T cells by rituximab treatment

(2009) Esther Wilk et al.   ARTHRITIS AND RHEUMATISM

Cellular mechanisms of IL-17-induced blood-brain barrier disruption

(2009) Jula Huppert et al.   FASEB JOURNAL

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE